HF
UTHR icon

HRT Financial’s United Therapeutics UTHR Stock Holding History

HRT Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.6M Buy
98,864
+32,022
+48% +$18M 0.1% 183
2026
Q1 		$39.6M Buy
66,842
+3,445
+5% +$1.72M 0.1% 167
2025
Q4 		$30.9M Sell
63,397
-12,241
-16% -$5.7M 0.1% 146
2025
Q3 		$31.7M Buy
+75,638
New +$25.4M 0.12% 106
2025
Q1 		– Sell
-9,528
Closed -$3.36M – 3442
2024
Q4 		$3.36M Sell
9,528
-1,724
-15% -$634K 0.02% 544
2024
Q3 		$4.03M Buy
+11,252
New +$3.8M 0.02% 561
2024
Q2 		– Sell
-17,306
Closed -$3.98M – 3160
2024
Q1 		$3.98M Buy
17,306
+11,714
+209% +$2.64M 0.02% 332
2023
Q4 		$1.23M Buy
5,592
+960
+21% +$221K 0.01% 886
2023
Q3 		$1.05M Buy
4,632
+1,807
+64% +$416K 0.01% 940
2023
Q2 		$623K Sell
2,825
-32,876
-92% -$7.28M 0.01% 1242
2023
Q1 		$8M Buy
35,701
+8,722
+32% +$2.15M 0.1% 178
2022
Q4 		$7.5M Buy
26,979
+24,041
+818% +$6.07M 0.11% 175
2022
Q3 		$615K Buy
+2,938
New +$657K 0.01% 1303
2022
Q2 		– Sell
-18,209
Closed -$3.27M – 3773
2022
Q1 		$3.27M Buy
18,209
+13,493
+286% +$2.57M 0.02% 425
2021
Q4 		$1.02M Sell
4,716
-10,107
-68% -$1.98M 0.01% 1097
2021
Q3 		$2.74M Buy
+14,823
New +$2.92M 0.02% 551
2021
Q2 		– Sell
-5,963
Closed -$997K – 3572
2021
Q1 		$997K Buy
+5,963
New +$994K 0.01% 1161
2020
Q3 		– Sell
-10,904
Closed -$1.32M – 2391
2020
Q2 		$1.32M Buy
+10,904
New +$1.23M 0.04% 457
2020
Q1 		– Sell
-2,312
Closed -$203K – 1383
2019
Q4 		$203K Buy
+2,312
New +$203K 0.01% 940
2019
Q3 		– Sell
-21,567
Closed -$1.68M – 1615
2019
Q2 		$1.68M Buy
+21,567
New +$2.02M 0.11% 198

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HRT Financial's UTHR Position: Q2 2026 in Review

HRT Financial increased its United Therapeutics (UTHR) stake by 48% in Q2 2026, buying an estimated $18M and bringing the position to 98,864 shares worth $53.6M. The position accounts for 0.1% of the portfolio, ranked #183.

HRT Financial first reported a position in UTHR in Q2 2019 and has held it in 20 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • HRT Financial held 98,864 shares of United Therapeutics worth $53.6M as of Q2 2026.
  • HRT Financial bought 32,022 United Therapeutics shares in Q2 2026, an estimated $18M.
  • United Therapeutics made up 0.1% of HRT Financial's portfolio in Q2 2026, its #183 holding.
  • HRT Financial first reported a position in United Therapeutics in Q2 2019 and has held it in 20 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.